Indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, Ised for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratiomg/g) in patients with type 2 diabetes and a history of hypertension.